Patents by Inventor Mark Darren Hulett

Mark Darren Hulett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Plant defensins and use in the treatment of proliferative diseases
    Patent number: 9540423
    Abstract: The present invention relates to compositions and methods for preventing or treating proliferative diseases. In particular, the present invention relates to the use of compositions derived or derivable from plants, such as plant defensins, particularly in methods for the prevention or treatment of proliferative diseases such as cancer. The present invention also relates to associated uses, systems and kits.
    Type: Grant
    Filed: October 19, 2012
    Date of Patent: January 10, 2017
    Assignees: BALMORAL AUSTRALIA PTY LTD, HEXIMA LIMITED
    Inventors: Mark Darren Hulett, Fung Tso Lay
  • NOVEL PLANT DEFENSINS AND USE IN THE TREATMENT OF PROLIFERATIVE DISEASES
    Publication number: 20150158918
    Abstract: The present invention relates to compositions and methods for preventing or treating proliferative diseases. In particular, the present invention relates to the use of compositions derived or derivable from plants, such as plant defensins, particularly in methods for the prevention or treatment of proliferative diseases such as cancer. The present invention also relates to associated uses, systems and kits.
    Type: Application
    Filed: October 19, 2012
    Publication date: June 11, 2015
    Applicants: HEXIMA LIMITED, BALMORAL AUSTRALIA PTY LTD
    Inventors: Mark Darren Hulett, Fung Tso Lay
  • NOVEL FORMS OF PLANT DEFENSINS
    Publication number: 20150004137
    Abstract: The present invention relates to heterogeneous or artificially created forms of plant defensins, and to uses of such heterogenous or artificially created defensins including methods for preventing or treating proliferative diseases. Compositions for use as animal and human medicaments are also provided. The present invention also relates to associated methods, uses, systems and kits.
    Type: Application
    Filed: October 19, 2012
    Publication date: January 1, 2015
    Applicant: BALMORAL AUSTRALIA PTY LTD
    Inventors: Mark Darren Hulett, Ivan Ka Ho Poon
  • TREATMENT OF PROLIFERATIVE DISEASES
    Publication number: 20120172313
    Abstract: The present invention relates to methods for preventing or treating proliferative diseases. In particular, the present invention relates to the use of compositions derived or derivable from plants, such as plant defensins, particularly in methods for the prevention or treatment of proliferative diseases such as cancer. The present invention also relates to associated uses, systems and kits.
    Type: Application
    Filed: June 23, 2011
    Publication date: July 5, 2012
    Inventors: MARK DARREN HULETT, IVAN KA HO POON, AMY ALEXANDRA BAXTER, MARILYN ANDERSON, FUNG LAY
  • Polypeptides with Fc binding ability
    Publication number: 20040213781
    Abstract: The present invention generally relates to molecules having Fc binding ability such as those with Fc receptor-like activity. The present invention also relates to the molecules, nucleic acids encoding the molecules, antagonist compounds, pharmaceutical compositions comprising the molecules and compounds, methods for testing potential antagonists, methods for producing the polypeptides, methods of treatment of disease and other aspects.
    Type: Application
    Filed: July 31, 2003
    Publication date: October 28, 2004
    Inventors: Phillip Mark Hogarth, Ian Farquhar Campbell McKenzie, Ross Ian Baker, Mark Darren Hulett, Maree Sharne Powell
  • Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
    Patent number: 6242238
    Abstract: The present invention relates to isolated or recombinant mammalian endoglucuronidase enzymes, polypeptides and peptides, in particular human, murine and rat heparanases, genetic sequences encoding same and uses therefor, for example in the determination and characterisation of chemical compounds, proteins, polypeptides, small molecules and macromolecules capable of inhibiting metastasis, angiogenesis, angioplasty-induced restenosis, atherosclerosis, inflammation, promote wound healing and otherwise modulate physiological processes involving heparanase cleavage of heparan sulphate. The invention further relates to a method of altering, modifying or otherwise modulating the level of expression of mammalian heparanase in a cell. A further aspect of the invention relates to immunoreactive molecules capable of binding to and/or inhibiting mammalian heparanase, in particular monoclonal antibodies.
    Type: Grant
    Filed: October 28, 1998
    Date of Patent: June 5, 2001
    Assignee: The Australian National University
    Inventors: Craig Geoffrey Freeman, Mark Darren Hulett, Christopher Richard Parish, Brenton James Hamdorf